Goetz et al. MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer. J Clin Oncol 35:3638-3646. Johnston S et al. MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer NPJ Breast Cancer...
HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study. Lancet Oncol. 2015 Jan;16(1):25-35. Epub 2014 Dec 16.
Goetz et al. MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer. J Clin Oncol 35:3638-3646. Johnston S et al. MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer NPJ Breast Cancer. 2019 Jan 17;5:5. Verzenios Eu smPC. H...
PLUSDo your Biblical studies anywhere! Access $3,100 worth of premium resources on the go! Upgrade toBible Gateway Plusand get the best value in digital Bible study. All Study Bibles Encyclopedias Commentaries Dictionaries Bible Studies Maps ...
英文标题:Effect of Amivantamab Dose Interruptions on Efficacy and Safety of First-line Amivantamab Plus Lazertinib in EGFR-mutant Advanced NSCLC:Exploratory Analyses from the MARIPOSA study 中文标题:MARIPOSA研究的探索性分析:埃万妥单抗中断对于埃万妥单抗+拉泽替尼一线治疗EGFR突变晚期NSCLC疗效和安全性的...
PLUSDo your Biblical studies anywhere! Access $3,100 worth of premium resources on the go! Upgrade toBible Gateway Plusand get the best value in digital Bible study. All Study Bibles Encyclopedias Commentaries Dictionaries Bible Studies Maps ...
1. Finn RS, Crown JP, Lang I, et al. The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanc...
英文标题:Subcutaneous amivantamab administered every 4 weeks (Q4W) in patients with advanced solid malignancies:The phase 1b PALOMA study 中文标题:埃万妥单抗每4周一次皮下给药治疗晚期实体恶性肿瘤患者:Ib期PALOMA研究 讲者:Natash...
1. Finn RS, Crown JP, Lang I, et al. The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanc...
Johnston S et al. MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer NPJ Breast Cancer. 2019 Jan 17;5:5. Verzenios Eu smPC. Hortobagyi G, et al. Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer. N Engl J Med....